News from sinovac biotech co., ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 05, 2014, 06:00 ET

Sinovac Announces New Presentation Time for Aegis Healthcare & Technology Conference

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced a new presentation time for the Aegis...

Sep 02, 2014, 06:00 ET

Sinovac to Participate in Upcoming Investor Conferences

 Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management...

Aug 27, 2014, 06:00 ET

Sinovac Announces Results of 2014 Annual General Meeting of Shareholders

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2014...

Aug 14, 2014, 12:49 ET

Sinovac Reports Unaudited Second Quarter Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and...

Jul 25, 2014, 05:00 ET

Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...

Jul 23, 2014, 06:00 ET

Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the...

Jul 21, 2014, 06:00 ET

Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the...

Jul 14, 2014, 06:00 ET

Sinovac Schedules 2014 Annual Meeting of Shareholders

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2014 Annual...

Jun 25, 2014, 06:00 ET

Sinovac Announces Favorable Reduction in Value Added Tax Rate

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the value added tax (or "VAT")...

May 21, 2014, 18:00 ET

Sinovac Reports Unaudited First Quarter 2014 Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter...

May 12, 2014, 06:00 ET

Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...

Apr 28, 2014, 06:09 ET

Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV)

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development,...

Apr 24, 2014, 06:00 ET

Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60...

Apr 16, 2014, 09:15 ET

Sinovac Files 2013 Annual Report on Form 20-F

BEIJING, April 16, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China...

Mar 19, 2014, 18:00 ET

Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and...

Mar 12, 2014, 06:00 ET

Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...

Feb 26, 2014, 17:01 ET

Sinovac's EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine

 Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial...

Jan 29, 2014, 07:07 ET

Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus

Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical...

Nov 12, 2013, 18:00 ET

Sinovac Reports Unaudited Third Quarter 2013 Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter...

Nov 07, 2013, 07:00 ET

Sinovac Receives Jiangsu Province Tender Award to Supply Inactivated Hepatitis Vaccine Healive(R) under Expanded Immunization Program

 Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine manufacturer, announced today that it has been selected by the Jiangsu...